Profitelligence Profitelligence · Filing Ledger Open COR research →

Form 8-K · Current Report · Filed 2026-02-10

Cencora Revises Segment Reporting Structure

Cencora, Inc. has revised its segment reporting structure to align with its growth priorities and strategic drivers. The new structure, effective from the first quarter of fiscal 2026, consists of U.S. Healthcare Solutions, International Healthcare Solutions, and Other. This revision is intended to update previously reported segment results in the 2025 Form 10-K to conform to the re-aligned reporting structure.

Filer
Cencora Inc. COR · NYSE
Filed
Accession
0001140859-26-000012
CIK
0001140859
Signal
High impactHealthcare

Items reported

Item events

Reported Item

Restructuring Costs Key Executive Appointment Key Executive Departure

Market reaction

Close before filing

$363.27

Next session

+0.7%

Since filing

-14.3%

Latest close

$311.34

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from COR reporting the same item, with the next session's move:

About Cencora Inc.

Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another COR filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts